Vivera Pharmaceuticals is a science-led, research and development biopharmaceutical company. The Company holds a global license to develop cannabinoid pharmaceutical products in the internationally patented, Tabmelt® drug-delivery system. The Company’s goal is to reach patients worldwide with their innovative, hemp-based cannabinoid biopharmaceutical products.